Tempus XF Liquid Biopsy Assay Demonstrates Extensive Analytical And Clinical Validity In Npj Precision Oncology Study
CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced results from validation studies demonstrating the reliable analytical performance of the Tempus|xF liquid biopsy. When validated against methods…